Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9


Vaccinia Virus Shuffling: deVV5, a Novel Chimeric Poxvirus with Improved Oncolytic Potency.

Ricordel M, Foloppe J, Antoine D, Findeli A, Kempf J, Cordier P, Gerbaud A, Grellier B, Lusky M, Quemeneur E, Erbs P.

Cancers (Basel). 2018 Jul 10;10(7). pii: E231. doi: 10.3390/cancers10070231.


TG1042 (Adenovirus-interferon-╬│) in primary cutaneous B-cell lymphomas: a phase II clinical trial.

Dreno B, Urosevic-Maiwald M, Kim Y, Guitart J, Duvic M, Dereure O, Khammari A, Knol AC, Derbij A, Lusky M, Didillon I, Santoni AM, Acres B, Bataille V, Chenard MP, Bleuzen P, Limacher JM, Dummer R.

PLoS One. 2014 Feb 24;9(2):e83670. doi: 10.1371/journal.pone.0083670. eCollection 2014.


Oncolytic vaccinia virus: a silver bullet?

Lusky M, Erbs P, Foloppe J, Acres RB.

Expert Rev Vaccines. 2010 Dec;9(12):1353-6. doi: 10.1586/erv.10.137. No abstract available.


Targeted chemotherapy for head and neck cancer with a chimeric oncolytic adenovirus coding for bifunctional suicide protein FCU1.

Dias JD, Liikanen I, Guse K, Foloppe J, Sloniecka M, Diaconu I, Rantanen V, Eriksson M, Hakkarainen T, Lusky M, Erbs P, Escutenaire S, Kanerva A, Pesonen S, Cerullo V, Hemminki A.

Clin Cancer Res. 2010 May 1;16(9):2540-9. doi: 10.1158/1078-0432.CCR-09-2974. Epub 2010 Apr 13.


Phase II clinical trial of intratumoral application of TG1042 (adenovirus-interferon-gamma) in patients with advanced cutaneous T-cell lymphomas and multilesional cutaneous B-cell lymphomas.

Dummer R, Eichm├╝ller S, Gellrich S, Assaf C, Dreno B, Schiller M, Dereure O, Baudard M, Bagot M, Khammari A, Bleuzen P, Bataille V, Derbij A, Wiedemann N, Waterboer T, Lusky M, Acres B, Urosevic-Maiwald M.

Mol Ther. 2010 Jun;18(6):1244-7. doi: 10.1038/mt.2010.52. Epub 2010 Apr 6.


Cellular localization and activity of Ad-delivered GFP-CFTR in airway epithelial and tracheal cells.

Granio O, Norez C, Ashbourne Excoffon KJ, Karp PH, Lusky M, Becq F, Boulanger P, Zabner J, Hong SS.

Am J Respir Cell Mol Biol. 2007 Dec;37(6):631-9. Epub 2007 Jul 19.


Good manufacturing practice production of adenoviral vectors for clinical trials.

Lusky M.

Hum Gene Ther. 2005 Mar;16(3):281-91. Review.


Identification of the glycosylation site of the adenovirus type 5 fiber protein.

Cauet G, Strub JM, Leize E, Wagner E, Van Dorsselaer A, Lusky M.

Biochemistry. 2005 Apr 12;44(14):5453-60.


Transductional targeting with recombinant adenovirus vectors.

Legrand V, Leissner P, Winter A, Mehtali M, Lusky M.

Curr Gene Ther. 2002 Sep;2(3):323-39. Review.


Supplemental Content

Loading ...
Support Center